nashpharmaceuticals.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Allow: / Disallow: /countclicks/ Sitemap: | ||
Meta Tags
| Title | Home - Nash |
| Description | About Developing therapies to fight fatty liver |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 172.67.223.110 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
nashpharmaceuticals.com Valuation
|
US$426,262
Last updated: 2023-05-14 18:10:47
nashpharmaceuticals.com has Semrush global rank of 24,830,562. nashpharmaceuticals.com has an estimated worth of US$ 426,262, based on its estimated Ads revenue. nashpharmaceuticals.com receives approximately 49,184 unique visitors each day. Its web server is located in United States, with IP address 172.67.223.110. According to SiteAdvisor, nashpharmaceuticals.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$426,262 |
| Daily Ads Revenue | US$394 |
| Monthly Ads Revenue | US$11,805 |
| Yearly Ads Revenue | US$141,650 |
| Daily Unique Visitors | 3,279 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| nashpharmaceuticals.com. 300 | A | nashpharmaceuticals.com. 300 | IP: 172.67.223.110 |
| nashpharmaceuticals.com. 300 | A | nashpharmaceuticals.com. 300 | IP: 104.21.94.122 |
| nashpharmaceuticals.com. 300 | AAAA | nashpharmaceuticals.com. 300 | IPV6: 2606:4700:3032::ac43:df6e |
| nashpharmaceuticals.com. 300 | AAAA | nashpharmaceuticals.com. 300 | IPV6: 2606:4700:3034::6815:5e7a |
| nashpharmaceuticals.com. 86400 | NS | nashpharmaceuticals.com. 86400 | NS Record: coco.ns.cloudflare.com. |
| nashpharmaceuticals.com. 86400 | NS | nashpharmaceuticals.com. 86400 | NS Record: grant.ns.cloudflare.com. |
HtmlToTextCheckTime:2023-05-14 18:10:47
| NASH Pharmaceuticals Nash Pharmaceuticals Inc is a privately held drug development company focusing on developing repurposed therapeutic drugs. The company has developed data that supports the advancement of up to 7 drug candidates into phase II trials in the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). HOME Services ▾ Compounded Specialty Care About Us Our Community Patient Resource Insurance Accepted Careers Contact Us About Us Nash Pharmaceuticals is a Canadian drug development company focusing on developing repurposed therapeutic drugs. Drug repurposing (also known as re-profiling, re-tasking or therapeutic switching) is the application of approved drugs and compounds to treat a different disease than what it originally developed for. Nash’s business model seeks to minimize investment and drug development risk by taking advantage of regulatory approved drugs and discovering alternative clinical uses by |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 23 Dec 2021 20:20:36 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Thu, 23 Dec 2021 21:20:36 GMT
Location: https://nashpharmaceuticals.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=SNyJzUbe%2FFJHWt82KNNYmZWjFnEt901F66dJsocLiCNREn2r%2FzSE6CS%2BbL%2FOjydLcS5WQTPRpY19O%2FcGK9nhx7CHqk9yKE49kinGZyOqBe371%2FDFx3wvNw8IQwa8St7u5qUvkeT0iNc%2Ftg%3D%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6c244a9f08df179d-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
HTTP/2 200
date: Thu, 23 Dec 2021 20:20:36 GMT
content-type: text/html; charset=utf-8
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=OS73QcWVwvkXUGUcdK9c8aAXAVYVwt7gc4pdFuKiM6bLj6g4HO5s%2FQlWm8gsDovgqCq0v6KcIwjFqAgjJVlDdUw9XjE5Gl9wlMCM18VRPVvpAVHysbt56MWmJIGnYybFCa6pltA8d5LjPg%3D%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6c244a9f3fce18aa-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
|
nashpharmaceuticals.com Whois Information
Domain Name: NASHPHARMACEUTICALS.COM Registry Domain ID: 2418222049_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-09-11T18:03:21Z Creation Date: 2019-07-29T21:42:01Z Registry Expiry Date: 2022-07-29T21:42:01Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: COCO.NS.CLOUDFLARE.COM Name Server: GRANT.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-26T07:25:12Z <<< |